Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2006 1
2007 1
2009 1
2010 1
2011 2
2012 1
2015 1
2016 1
2017 3
2018 3
2019 2
2020 4
2021 2
2022 3
2023 4
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.
Lambertini M, Boni L, Michelotti A, Magnolfi E, Cogoni AA, Mosconi AM, Giordano M, Garrone O, Arpino G, Poggio F, Cinacchi P, Bighin C, Fregatti P, Pronzato P, Blondeaux E, Del Mastro L; GIM study group. Lambertini M, et al. Among authors: magnolfi e. J Natl Cancer Inst. 2022 Mar 8;114(3):400-408. doi: 10.1093/jnci/djab213. J Natl Cancer Inst. 2022. PMID: 34850043 Free PMC article. Clinical Trial.
Pain and Frailty in Hospitalized Older Adults.
Ardoino I, Franchi C, Nobili A, Mannucci PM, Corli O; REPOSI Investigators. Ardoino I, et al. Pain Ther. 2020 Dec;9(2):727-740. doi: 10.1007/s40122-020-00202-3. Epub 2020 Oct 15. Pain Ther. 2020. PMID: 33058084 Free PMC article. Review.
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial.
Poggio F, Blondeaux E, Tagliamento M, Perachino M, Nardin S, Conte B, Giuliano M, Arpino G, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Magnolfi E, Gasparro S, Fabi A, Garrone O, Alicicco MG, Urracci Y, Poletti P, Correale P, Molinelli C, Fozza A, Puglisi F, Colantuoni G, Fregatti P, Boni L, Lambertini M, Del Mastro L. Poggio F, et al. Among authors: magnolfi e. ESMO Open. 2024 Aug;9(8):103650. doi: 10.1016/j.esmoop.2024.103650. Epub 2024 Aug 8. ESMO Open. 2024. PMID: 39121814 Free PMC article. Clinical Trial.
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER).
De Angelis C, Pagliuca M, Magnolfi E, Mansutti M, Ballatore Z, De Laurentiis M, Bordonaro R, Leonardi V, Bruzzese D, Caputo R, Mosconi AM, Cinieri S, Fabi A, Del Mastro L, Puglisi F, De Placido S, Giuliano M, Arpino G. De Angelis C, et al. Among authors: magnolfi e. Oncologist. 2025 Jul 4;30(7):oyaf200. doi: 10.1093/oncolo/oyaf200. Oncologist. 2025. PMID: 40591514 Free PMC article. Clinical Trial.
Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.
Cazzaniga ME, Pronzato P, Amoroso D, Arpino G, Atzori F, Beano A, Biganzoli L, Bisagni G, Blasi L, Capello C, Chiari R, D'Alonzo A, De Laurentiis M, Denaro A, Fabi A, Farci D, Ferraù F, Fiorio E, Gennari A, Giotta F, Giovanardi F, Gregorc V, Livi L, Magnolfi E, Mosconi AM, Palumbo R, Pugliese P, Putzu C, Ricciardi GRR, Riccardi F, Scortichini L, Spazzapan S, Tagliaferri P, Tinari N, Tonini G, Vandone AM, Mustacchi G. Cazzaniga ME, et al. Among authors: magnolfi e. Cancers (Basel). 2025 May 20;17(10):1715. doi: 10.3390/cancers17101715. Cancers (Basel). 2025. PMID: 40427212 Free PMC article.
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients.
Cicco S, D Abbondanza M, Proietti M, Zaccone V, Pes C, Caradio F, Mattioli M, Piano S, Marra AM, Nobili A, Mannucci PM, Pietrangelo A, Sesti G, Buzzetti E, Salzano A, Cimellaro A; Giovani Internisti Società Italiana di Medicina Interna (GIS-SIMI) and of the REPOSI Investigators. Cicco S, et al. Eur J Clin Invest. 2023 Apr;53(4):e13931. doi: 10.1111/eci.13931. Epub 2022 Dec 21. Eur J Clin Invest. 2023. PMID: 36453932 Free article.
Premedication for irinotecan.
Zampa G, Magnolfi E, Borgomastro A. Zampa G, et al. Among authors: magnolfi e. J Clin Oncol. 2000 Jan;18(1):237. J Clin Oncol. 2000. PMID: 10623719 No abstract available.
30 results